J&J Petitions Supreme Court On Pre-emption, ‘Clear Evidence’ In OTC Litigation

Johnson & Johnson files a writ of certiorari asking the Supreme Court to review a $140m judgment against the firm in Massachusetts. Questions over “clear evidence” needed for FDA decision to pre-empt state courts are at heart of issue and need the court’s consideration.